← Eichor
Study identifier: NCT07037927 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Minnesota RETAIN Phase 3

Condition: Injuries Related Work · Illness Related Work · Disability  ·  Sponsor: Mayo Clinic

PhaseNA
Planned participants1000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

MN RETAIN Phase 3 is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Education (DOE). There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), and stakeholders throughout MN. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic a subrecipients of the grant.

This description comes directly from the study's public registry record.

Talk to the study team

Samantha Westphal, MSN, RN, PHN  ·  507-422-6407  ·  westphal.samantha@mayo.edu

Courtney Fick, SOCRA, CCRP  ·  507-538-6562  ·  fick.courtney@mayo.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Mayo Clinic RochesterRochester, Minnesota, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07037927